RBC Capital maintains Outperform on Acadia Pharmaceuticals, lowers PT to $32.

jueves, 6 de noviembre de 2025, 10:54 am ET1 min de lectura
ACAD--

RBC Capital maintains Outperform on Acadia Pharmaceuticals, lowers PT to $32.

RBC Capital maintains Outperform on Acadia Pharmaceuticals, lowers PT to $32.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios